A recent study found that statin use can reduce breast cancer death and recurrence by roughly 20%.
The study, published June 12 in the British Journal of Cancer, analyzed 34 studies that included 689,990 women with breast cancer.
Researchers found that lipophilic stains had more protective effects against death than hydrophilic statins, but not recurrence. The differences in outcomes by subgroup were not statistically significant.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.